Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | +20.00% | -14.29% |
Apr. 16 | ADRs End Lower, Purple Biotech Ltd. Declines 29% | DJ |
Apr. 12 | ADRs End Lower, Leju Holdings Ltd. Declines 72% | DJ |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 17-04-30 |
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 14-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Peter Marks
BRD | Director/Board Member | 68 | 05-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 11-08-07 |
Brian Meltzer
BRD | Director/Board Member | 70 | 99-12-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,802,360,380 | 2,436,015,074 ( 86.93 %) | 0 | 86.93 % |
Company contact information
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 20.39M | |
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+46.00% | 41.25B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- ATH Stock
- Company Alterity Therapeutics Limited